Patients With Inflammatory Bowel Disease Are at Increased Risk of Respiratory Syncytial Virus Infections After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Propensity-Matched Cohort Analysis
Adults with IBD have a higher risk of RSV infection after SARS-CoV-2 infection, particularly those receiving steroids or immune therapies. SARS-CoV-2 infection may have contributed to the recent RSV infection surge in this population, warranting further research.
Authors
- Mary S. Hayney (ORCID: https://orcid.org/0000-0003-3307-5634)
- Francis A. Farraye (ORCID: https://orcid.org/0000-0001-6371-2441)
- Oscar Ramirez Ramirez (ORCID: https://orcid.org/0000-0003-1714-9461)
- Freddy Caldera (ORCID: https://orcid.org/0000-0003-1960-6611)
- Saqr Alsakarneh (ORCID: https://orcid.org/0000-0002-8776-2176)
- Jana G. Hashash (ORCID: https://orcid.org/0000-0001-8305-9742)
Institutions
- University of Wisconsin–Madison (US)
- Jacksonville College (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
- Wisconsin Division of Public Health (US)
- University of Missouri–Kansas City (US)
Publication Details
- Journal
- Clinical and Translational Gastroenterology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.14309/ctg.0000000000000840
- Citations
- 2
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.71